Stephanie Culler, Ph.D.
Co-Founder and CEO, Persephone Biosciences
Professional Overview
Dr. Stephanie Culler is the Co-Founder and CEO of Persephone Biosciences, a biotechnology company focused on developing novel therapeutics and diagnostics based on the human gut microbiome. With over a decade of experience in microbial engineering and biopharmaceutical research, she is a recognized expert in the field of microbiome-based therapies.
Experience Summary
Current Role
As the Co-Founder and CEO of Persephone Biosciences, Dr. Culler is responsible for driving the company's strategic vision, overseeing research and development initiatives, and leading a team of scientists and medical professionals. Under her leadership, Persephone has secured multiple rounds of funding and established partnerships with leading academic and industry organizations to advance its pipeline of microbiome-based therapeutics.
Career Progression
Prior to co-founding Persephone Biosciences, Dr. Culler held senior research scientist roles at Genomatica, where she contributed to the development of novel microbial production processes for sustainable chemicals. She also served as an HHMI Postdoctoral Scholar at the California Institute of Technology, where she conducted groundbreaking research on the interplay between the gut microbiome and human health.
Academic Background
Dr. Culler holds a Ph.D. in Chemical Engineering from the California Institute of Technology, where her doctoral research focused on the engineering of microbial systems for the production of biofuels and specialty chemicals. She also holds a Bachelor of Science degree in Chemical Engineering from the University of California, San Diego, where she gained experience as an undergraduate researcher.
Areas of Expertise
- Microbiome engineering and therapeutics
- Microbial fermentation and process development
- Bioinformatics and computational biology
- Translational research and clinical development
- Entrepreneurship and business strategy
Professional Impact
Dr. Culler's work has been recognized through numerous awards and accolades, including the HHMI Postdoctoral Fellowship, the Caltech Graduate Fellowship, and the Genomatica Excellence in Research Award. She has also authored several peer-reviewed publications in leading scientific journals and has contributed to the advancement of the field of microbiome-based therapies through her research and industry involvement.
Conclusion
With her deep expertise in microbial engineering, strong track record of scientific and entrepreneurial achievements, and a passion for improving human health through microbiome-based innovations, Dr. Stephanie Culler is poised to lead Persephone Biosciences to new heights in the rapidly evolving field of gut microbiome research and therapeutics.
